BSL3 management and practice of infectious disease research at HTRL
HTRL 传染病研究的 BSL3 管理和实践
基本信息
- 批准号:10793948
- 负责人:
- 金额:$ 246.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-18 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAccidentsAirAnimal ModelAntibiotic TherapyAntibioticsArticulationAwarenessBacteriaBacterial InfectionsBiologicalBiological AssayBiomedical ResearchBioterrorismBirdsCOVID-19COVID-19 pandemicCertificationChicagoClassificationClostridium difficileCollaborationsCommunicable DiseasesCommunitiesContainmentCoronavirusCountryDecontaminationDedicationsDengueDevelopmentDiseaseDoctor of PhilosophyEbola virusEconomicsEmergency SituationEmerging Communicable DiseasesEngineeringEnvironmentEnvironmental HealthEpidemicEquilibriumEvaluationEventFinancial SupportFosteringFrequenciesFunding OpportunitiesGenomeGoalsHealthHumanHuman ResourcesImmune responseImmunityIn VitroInfectionInfectious AgentInfectious Diseases ResearchInfluenzaInstitutionInvestigationKnowledgeLaboratoriesLaboratory PersonnelLeadershipLivestockMaintenanceMammalsMeasuresMedicalMicrobeMicrobiologyMiddle East Respiratory Syndrome CoronavirusModelingMolecularMorbidity - disease rateMutationNational Institute of Allergy and Infectious DiseaseOperations ResearchPanicPathogenicityPersonsPharmaceutical PreparationsPopulationPreventiveProceduresProtective DevicesProtocols documentationPublic HealthRNA VirusesRegulationResearchResearch ActivityResearch SupportResourcesRiskRoleSARS coronavirusSafetyScientistSecureServicesSocietiesStructureSystemTechnologyTestingTherapeutic InterventionToxinTrainingTraining ActivityTraining and EducationTraining and InfrastructureUniversitiesVaccinesVariantViralVirulenceVirusZIKAZoonosesbiodefensebiosafety level 3 facilitybiosecuritychikungunyacombatcompanion animalcostdrug resistant pathogenhazardhuman diseaseimprovedin vivoinsightmedical countermeasuremeetingsmethicillin resistant Staphylococcus aureusmicrobialoperationpathogenpathogenic microbepreventpreventive interventionprofessorpublic health emergencyrepairedresponsetransmission processviral outbreakvirtualweb portal
项目摘要
PROJECT ABSTRACT (OVERALL)
Our nation’s ability to detect, prevent and counter bioterrorism and emerging infectious diseases depends on
technologies that are generated through biomedical research on disease-causing microbes and understanding
human immune responses to infection. Following bioterrorism events in 2001, the National Institute of Allergy
and Infectious Diseases established the Regional Biocontainment Laboratory (RBL) Network, to promote safe
research in 12 Biosafety Level 3 (BSL3) laboratories. In turn, Institutions and Universities hosting these RBLs
sustained the management of these facilities, fostered a strong Biosafety culture, and fueled research inquiries
into the molecular mechanisms whereby microbes cause human disease. The University of Chicago hosts the
Regional Biocontainment Howard Taylor Ricketts Laboratory (HTRL) operated by its Department of
Microbiology since 2009. When this nation began to implement shutdowns to prevent the spread of COVID-19,
essential professionals at the HTRL continued key management operations and pivoted their expertise to study
SARS-CoV2. This momentum would not have been possible without the existing expertise and dedication of
engineers, biosafety officers, veterinary staff, scientists, as well as financial support from the University. The
goal of this proposal is to present a plan to maintain the safe operation and management of the BSL3 space of
the Regional Biocontainment HTRL and to continue training professionals who will provide research support
services for the development of measures necessary to mitigate and protect the public's health from infectious
diseases that may be the result of intentional, accidental, or naturally occurring health emergency. This plan
will be implemented by three cores. Core 1 Facility Management, Maintenance and Operations
(C1Facilities@HTRL) led by George Langan, describes activities that support continuous BSL3 containment
through decontamination, retesting, certification, preventive maintenance, repair or replacement of building
systems and compliance with Biosecurity, Environmental Health, and Biosafety regulations. Core 2 BSL3
Practices (C2BSL3Practice@HTRL) led by Joseph Kanabrocki, describes activities for the training of
personnel and the development of Standard Operating Procedures as well as activities to sustain a safe and
secure environment. Core 3 Biocontainment Research Support Services (C3ResearchSupport@HTRL)
led by Dominique Missiakas, describes research capabilities for the study of Risk Group 3 and Select Agent
pathogens. HTRL will use a web-based portal to advertise and offer research services such as isolation and
characterization of pathogens, virulence and countermeasure studies using in vitro and in vivo assays and
animal models. Monthly virtual and annual in-person meetings between RBL Directors will identify
opportunities for collaborations, improvements, and cross-training. These interactions will expand the capacity
of the RBL network as a whole to respond to public health emergencies, conduct evaluations of threats and
countermeasures, and provide education and training to conform with biosafety standards.
项目摘要(总体)
我们国家发现、预防和打击生物恐怖主义和新发传染病的能力取决于
通过对致病微生物的生物医学研究和理解而产生的技术
2001 年生物恐怖主义事件后,国家过敏研究所研究了人类对感染的免疫反应。
和传染病建立了区域生物防护实验室(RBL)网络,以促进安全
12 个生物安全 3 级 (BSL3) 实验室的研究,以及托管这些 RBL 的机构和大学。
持续管理这些设施,培育强大的生物安全文化,并推动研究调查
芝加哥大学主办了微生物引起人类疾病的分子机制。
区域生物防护霍华德·泰勒·里基茨实验室 (HTRL),由其部门运营
自 2009 年以来的微生物学。当这个国家开始实施封锁以防止 COVID-19 传播时,
HTRL 的重要专业人员继续进行关键管理运营,并将他们的专业知识用于学习
如果没有 SARS-CoV2 现有的专业知识和奉献精神,这种势头是不可能实现的。
工程师、生物安全官员、兽医人员、科学家以及大学的财政支持。
该提案的目标是提出一项计划,以维持 BSL3 空间的安全运营和管理
区域生物防护 HTRL 并继续培训提供研究支持的专业人员
制定必要措施以减轻和保护公众健康免受传染病侵害的服务
可能因故意、意外或自然发生的健康紧急情况而导致的疾病。
将由三个核心实施:核心 1 设施管理、维护和运营。
(C1Facilities@HTRL) 由 George Langan 领导,描述了支持持续 BSL3 遏制的活动
通过净化、重新测试、认证、预防性维护、修理或更换建筑物
系统并遵守生物安全、环境健康和生物安全核心 2 BSL3 法规。
由 Joseph Kanabrocki 领导的实践 (C2BSL3Practice@HTRL) 描述了培训活动
人员和标准操作程序的制定以及维持安全和安全的活动
安全环境。核心 3 生物防护研究支持服务 (C3ResearchSupport@HTRL)
由 Dominique Missiakas 领导,描述了风险组 3 和选择代理的研究能力
HTRL 将使用基于网络的门户网站来宣传并提供研究服务,例如隔离和治疗。
使用体外和体内测定法表征病原体、毒力和对策研究
RBL 董事之间的每月虚拟会议和年度面对面会议将确定动物模型。
这些互动将扩大能力。
RBL 网络作为一个整体来应对突发公共卫生事件、进行威胁评估和
对策,并提供符合生物安全标准的教育和培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOSEPH A. KANABROCKI其他文献
JOSEPH A. KANABROCKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOSEPH A. KANABROCKI', 18)}}的其他基金
相似国自然基金
驾驶行为随机异变下的交通事故风险演化规律解析与建模
- 批准号:52372337
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
多入口下穿隧道合流区域交通事故演化机理与自解释调控方法
- 批准号:52302437
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高快速路突发事故情景下避险驾驶人“感知-决策-行为”关联机制与安全驾驶韧性提升方法
- 批准号:52372324
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
核电厂严重事故后放射性碘的传质与化学过程协同演化机理研究
- 批准号:12375176
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
面向危化品运输事故的多源稀疏轨迹增强表示学习
- 批准号:42301526
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的病理生理机制
- 批准号:
10708438 - 财政年份:2023
- 资助金额:
$ 246.91万 - 项目类别:
HazMat Risk Management, Readiness and Training Platform
HazMat 风险管理、准备和培训平台
- 批准号:
10685138 - 财政年份:2023
- 资助金额:
$ 246.91万 - 项目类别:
Extending Reach, Accuracy, and Therapeutic Capabilities: A Soft Robot for Peripheral Early-Stage Lung Cancer
扩大范围、准确性和治疗能力:用于周围早期肺癌的软机器人
- 批准号:
10637462 - 财政年份:2023
- 资助金额:
$ 246.91万 - 项目类别:
HazMat Risk Management, Readiness and Training Platform
HazMat 风险管理、准备和培训平台
- 批准号:
10685138 - 财政年份:2023
- 资助金额:
$ 246.91万 - 项目类别:
Novel Myofunctional Therapy Water Bottle to Reduce Obstructive Sleep Apnea and Snoring
新型肌功能治疗水瓶可减少阻塞性睡眠呼吸暂停和打鼾
- 批准号:
10385206 - 财政年份:2022
- 资助金额:
$ 246.91万 - 项目类别: